Form 8-K - Current report:
SEC Accession No. 0001104659-24-126760
Filing Date
2024-12-09
Accepted
2024-12-09 16:15:33
Documents
14
Period of Report
2024-12-09
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2430501d1_8k.htm   iXBRL 8-K 31030
2 EXHIBIT 99.1 tm2430501d1_ex99-1.htm EX-99.1 33137
  Complete submission text file 0001104659-24-126760.txt   248123

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cgc-20241209.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgc-20241209_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cgc-20241209_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2430501d1_8k_htm.xml XML 3555
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38496 | Film No.: 241535291
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)